EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Cannabis use among cancer patients and survivors in the United States: a systematic review

Samia Amin iD, Si Woo Chae, Crissy T Kawamoto iD, Kristina T Phillips, Pallav Pokhrel iD

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae004 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Samia Amin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Population Sciences Program, University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

How cannabis products are being used by cancer patients and survivors in the United States is poorly understood. This study reviewed observational data to understand the modes, patterns, reasons, discontinuation, and adverse experiences of cannabis use.

Methods

PubMed and PsycINFO database searches were conducted between May 2022 and November 2022. Of the 1162 studies identified, 27 studies met the inclusion criteria. The intercoder agreement was strong (0.81).

Results

The majority (74%) of the studies were cross-sectional in design. Study samples were approximately equal proportions of men and women and majority White participants. The prevalence of cannabis use based on national samples ranged between 4.8% and 22%. The most common modes of cannabis intake were topical application (80%), smoking (73%), vaping (12%), and ingestion of edible products (10%). Younger age, male gender, being a current or former smoker, and higher socioeconomic status were associated with greater likelihood of cannabis use. The main motive for cannabis use was management of symptoms due to cancer or cancer treatment such as pain, nausea, lack of sleep, and anxiety. A majority of the participants across studies reported that cannabis helped reduce these symptoms. Lack of symptom improvement, side effects such as fatigue and paranoia, cost, and social stigma were identified as some of the reasons for discontinuing cannabis use.

Conclusions

It appears that cannabis may help cancer patients and survivors manage symptoms. However, more longitudinal studies are needed to determine whether positive experiences of cannabis use outweigh adverse experiences over time in this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsHumansUnited StatesMaleFemaleCross-Sectional StudiesSex FactorsMiddle AgedVapingAge FactorsAdultAnxietyNauseaFatigueMotivationPrevalenceMedical MarijuanaMarijuana SmokingSocial ClassObservational Studies as TopicCancer Pain

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Population Sciences Program, University of Hawai'i Cancer Center, University of Hawai'i at Manoa, Honolulu, HI, USA.
  • Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI, USA.

ORCID-Profile: Samia Amin, Crissy T Kawamoto, Pallav Pokhrel

Förderung

  • NCI NIH HHS

Zitieren

APA

Amin, S., Chae, S. W., Kawamoto, C. T., Phillips, K. T., & Pokhrel, P. (2024). Cannabis use among cancer patients and survivors in the United States: a systematic review. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae004

Vancouver

Amin S, Chae SW, Kawamoto CT, Phillips KT, Pokhrel P. Cannabis use among cancer patients and survivors in the United States: a systematic review. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae004

BibTeX
@article{Amin2024,
  author = {Amin, Samia and Chae, Si Woo and Kawamoto, Crissy T and Phillips, Kristina T and Pokhrel, Pallav},
  title = {Cannabis use among cancer patients and survivors in the United States: a systematic review},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae004}
}
Kostenlos starten →